Response to: SARS-CoV-2 associated Guillain-Barré syndrome in 62 patients.

Doneddu, P E; De Sanctis, P; Viganò, L; Selmi, C; Gentile, F; Nobile-Orazio, E

Doneddu, P E; De Sanctis, P; Viganò, L; Selmi, C; Gentile, F; Nobile-Orazio, E.

Afiliação

Doneddu PE; Department of Neurology, Neuromuscular and Neuroimmunology Service, Humanitas Clinical and Research Institute - IRCCS, Rozzano, Italy.
De Sanctis P; Department of Neurosurgery, Humanitas Clinical and Research Institute - IRCCS, Rozzano, Italy.
Viganò L; Department of General Surgery, Humanitas Clinical and Research Institute - IRCCS, Rozzano, Italy.
Selmi C; Department of Rheumatology and Clinical Immunology, Humanitas Clinical and Research Institute - IRCCS, Rozzano, Italy.
Gentile F; Department of Neurology, Neuromuscular and Neuroimmunology Service, Humanitas Clinical and Research Institute - IRCCS, Rozzano, Italy.
Nobile-Orazio E; Department of Neurology, Neuromuscular and Neuroimmunology Service, Humanitas Clinical and Research Institute - IRCCS, Rozzano, Italy.

Eur J Neurol ; 28(1): e9, 2021 01.

Article em En | MEDLINE | ID: mdl-32978868

Assuntos

COVID-19; Síndrome de Guillain-Barré; Síndrome de Guillain-Barré/complicações; Humanos; SARS-CoV-2

Palavras-chave

Covid; Guillain-Barre syndrome; cranial nerves; cranial neuropathy; neurological disorders; peripheral neuropathies

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Guillain-Barré / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Neurol Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google